Table 4

Angiographic results preprocedural and postprocedural and at 9 months follow-up

EES (n=85)BMS (n=87)p Value
Pre-PCI
Time from randomisation to PCI (hours)26.4±40.241.7±67.30.075
MLD (mm)0.81±0.420.81±0.400.928
Diameter stenosis (%)69.73±15.2869.00±14.920.711
Lesion length (mm)14.43±6.6313.39±7.030.234
Reference diameter pre-PCI (mm)2.73±0.522.65±0.550.304
Post-PCI
MLD (mm)2.36±0.572.30±0.460.163
Diameter stenosis (%)11.85±16.7513.06±10.800.107
Lesion length (mm)18.30±7.8817.58±7.080.709
Stent placement82/84 (97.6%)87/89 (97.8%)>0.99
Direct stenting27/82 (32.9%)32/87 (36.8%)0.599
Number of stents1.26±0.491.15±0.390.114
Maximal stent diameter (mm)3.14±0.433.13±0.450.660
Total stent length (mm)22.57±10.7421.47±7.720.825
Balloon size (mm)2.82±0.452.69±0.450.084
Acute gain (mm)1.53±0.501.50±0.520.498
Nine-month follow-upEES (n=60)BMS (n=64)
Time from randomisation to 9 months follow-up (months)8.9±1.69.2±2.40.468
MLD (mm)2.37±0.631.84±0.62<0.001
Diameter stenosis (%)11.25±18.0331.13±18.65<0.001
Binary restenosis*1/54 (1.9%)10/60 (16.7%)0.007
Late loss (mm)0.09±0.520.52±0.51<0.001
  • Values are mean±SD or count/sample size (%).

  • *diameter stenosis at 9 months follow-up >50%.

  • Acute gain, MLD after stenting minus MLD at baseline; Late loss, MLD after stenting minus MLD at follow-up; MLD, minimal lumen diameter.

  • BMS, bare-metal stent; EES, everolimus-eluting stent; PCI, percutaneous coronary intervention.